» Articles » PMID: 32245083

SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far

Overview
Journal Pathogens
Date 2020 Apr 5
PMID 32245083
Citations 312
Authors
Affiliations
Soon will be listed here.
Abstract

In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.

Citing Articles

Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research.

Xiao F, Hu J, Xu M, Wang D, Shen X, Zhang H Viruses. 2025; 17(1).

PMID: 39861889 PMC: 11768759. DOI: 10.3390/v17010100.


The Impact of COVID-19 on Burns: A Brazilian Study.

Moura C, Bittencourt M, Cazumba M, Buda A, Bowder A, Corlew D Eur Burn J. 2024; 4(1):1-8.

PMID: 39599965 PMC: 11571859. DOI: 10.3390/ebj4010001.


Sociodemographic, Clinical, and Ventilatory Factors Influencing COVID-19 Mortality in the ICU of a Hospital in Colombia.

Perlaza C, Cruz Mosquera F, Moreno Reyes S, Tovar Salazar S, Cruz Rojas A, Espana Serna J Healthcare (Basel). 2024; 12(22).

PMID: 39595491 PMC: 11593780. DOI: 10.3390/healthcare12222294.


Gene expression profiles of precursor cells identify compounds that reduce NRP1 surface expression in macrophages: Implication for drug repositioning for COVID-19.

Iwata A, Chelvanambi S, Asano T, Whelan M, Nakamura Y, Aikawa E Front Cardiovasc Med. 2024; 11:1438396.

PMID: 39512370 PMC: 11541348. DOI: 10.3389/fcvm.2024.1438396.


Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers.

Sababathy M, Ramanathan G, Ganesan S, Sababathy S, Yasmin A, Ramasamy R Braz J Med Biol Res. 2024; 57:e13219.

PMID: 39417447 PMC: 11484355. DOI: 10.1590/1414-431X2024e13219.


References
1.
Ramsey M, Nuttall J, Hart P . A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC). Trials. 2019; 20(1):501. PMC: 6694471. DOI: 10.1186/s13063-019-3606-y. View

2.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

3.
Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59(3):252-6. PMC: 1746980. DOI: 10.1136/thorax.2003.012658. View

4.
Glowacka I, Bertram S, Muller M, Allen P, Soilleux E, Pfefferle S . Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011; 85(9):4122-34. PMC: 3126222. DOI: 10.1128/JVI.02232-10. View

5.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z . SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020; 382(12):1177-1179. PMC: 7121626. DOI: 10.1056/NEJMc2001737. View